Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)

NCT02431208

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University Of Arkansas Little Rock, Arkansas, United States
  • Scripps Clinic Torrey Pines La Jolla, California, United States
  • UC Davis; Comprehensive Cancer Center Sacramento, California, United States
View all 31 locations
View Trial Details
Completed

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

NCT01753453

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Investigational Site Number 056002 Bruges, Belgium
  • Investigational Site Number 233001 Tallinn, Estonia
  • Investigational Site Number 440001 Vilnius, Lithuania
  • Investigational Site Number 752001 Stockholm, Sweden
View Trial Details
Completed

Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis

NCT03506386

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centro de Hematologia e Oncologia (CEHON) Salvador, Estado de Bahia, Brazil
  • Hospital Sao Rafael Salvador, Estado de Bahia, Brazil
  • Hospital das Clinicas da UFG Goiânia, Goiás, Brazil
  • Hospital das Clinicas da UFMG Belo Horizonte, Minas Gerais, Brazil
View all 17 locations
View Trial Details
Completed

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03477643

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Hospital de Sant Joan de Déu Barcelona, Spain
  • Hospital Donostia-Donostia Ospitalea Donostia / San Sebastian, Spain
  • Hospital Universitario Virgen de Las Nieves Granada, Spain
  • Hospital General San Jorge - Huesca Huesca, Spain
View all 27 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details

Related conditions